Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes

OBJECTIVE: Iguratimod, a novel disease-modifying anti-rheumatic drug for the treatment of rheumatoid arthritis, has been approved in China and Japan. Here, we aimed to find whether iguratimod can inhibit the aggressive behavior and promote apoptosis of rheumatoid fibroblast-like synoviocytes (RA-FLS...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Immunol Res
Autores principales: Lin, Jin, Yu, Ye, Wang, Xuanwei, Ke, Yini, Sun, Chuanyin, Yue, Lihuan, Xu, Guanhua, Xu, Bei, Xu, Liqin, Cao, Heng, Xu, Danyi, Olsen, Nancy, Chen, Weiqian
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6885276/
https://ncbi.nlm.nih.gov/pubmed/31828173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6929286
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares